Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
AstraZeneca
Moodys
Boehringer Ingelheim
McKinsey

Last Updated: January 29, 2022

Volunteer for clinical trials for GLUCAGON at ClinicalTrialExchange

DrugPatentWatch Database Preview

GLUCAGON - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for glucagon and what is the scope of freedom to operate?

Glucagon is the generic ingredient in five branded drugs marketed by Amphastar Pharms Inc, Lilly, Eli Lilly And Co, Xeris, Novo Nordisk, and Fresenius Kabi Usa, and is included in seven NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Glucagon has ninety-five patent family members in forty countries.

There are twelve drug master file entries for glucagon. Two suppliers are listed for this compound.

Summary for GLUCAGON
Drug Prices for GLUCAGON

See drug prices for GLUCAGON

Recent Clinical Trials for GLUCAGON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MilanPhase 3
University Medical Centre LjubljanaN/A
University of PalermoN/A

See all GLUCAGON clinical trials

Medical Subject Heading (MeSH) Categories for GLUCAGON

US Patents and Regulatory Information for GLUCAGON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eli Lilly And Co BAQSIMI glucagon POWDER;NASAL 210134-001 Jul 24, 2019 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-001 Sep 10, 2019 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Amphastar Pharms Inc GLUCAGON glucagon INJECTABLE;INJECTION 208086-001 Dec 28, 2020 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Lilly GLUCAGON glucagon hydrochloride INJECTABLE;INJECTION 012122-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Fresenius Kabi Usa GLUCAGON glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 201849-001 May 8, 2015 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Dow
Merck
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.